Lawsuits Challenge 340B Drug Pricing Program: E...

By Rene Pretorius

November 22, 2024

Eli Lilly and Johnson & Johnson (J&J) have filed lawsuits against the Health Resources and Services Administration (HRSA) regarding their proposed rebate models for the
Leveraging Bayh-Dole Act March-In Rights to Reduce US Drug Prices
Overview of NICE’s Elranatamab Managed Access Agreement
Innovative Pricing and Payment Models for Health Technologies
August 2024 Analysis of Türkiye’s Pharmaceutical Foreign Trade
NICE Collaborates with Menarini to Evaluate Elacestrant Breast Cancer Treatment
Enhancing Global Health through Regulatory Collaboration
Strategic Phased Launch of Tirzepatide for Obesity Treatment in England
The Trump Drug Policy Change: A Reverse Course
The Economic Impact of Obesity in Türkiye: A Micro-Costing Analysis
Addressing the Challenges of Value Attribution in Combination Therapies
Global Disparities in Pneumonia Vaccine Access
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...